These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1003 related items for PubMed ID: 20166851

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS, Rye DB.
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [Abstract] [Full Text] [Related]

  • 23. Narcolepsy: clinical approach to etiology, diagnosis, and treatment.
    Koziorynska EI, Rodriguez AJ.
    Rev Neurol Dis; 2011; 8(3-4):e97-106. PubMed ID: 22249574
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 28. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S, Gammeltoft S, Jennum PJ.
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Investigational therapies for the treatment of narcolepsy.
    de Biase S, Nilo A, Gigli GL, Valente M.
    Expert Opin Investig Drugs; 2017 Aug; 26(8):953-963. PubMed ID: 28726523
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U, Bassetti CL.
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Narcolepsy: genetic predisposition and neuropharmacological mechanisms. REVIEW ARTICLE.
    Nishino S, Okura M, Mignot E.
    Sleep Med Rev; 2000 Feb; 4(1):57-99. PubMed ID: 12531161
    [Abstract] [Full Text] [Related]

  • 36. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK, Gacuan D, George S, Sharif M, Bahammam AS.
    Clin Neuropharmacol; 2011 Feb; 34(1):1-4. PubMed ID: 21206362
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sodium oxybate for cataplexy.
    Lemon MD, Strain JD, Farver DK.
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 51.